Nanosonics Launches CORIS in UK Hospital, Eyes FY27 Commercial Rollout
Nanosonics is a pioneering Australian infection prevention company dedicated to transforming medical device reprocessing through innovative automated technology. Their flagship product, the trophon® system, provides high-level disinfection for ultrasound probes using a sophisticated hydrogen peroxide mist that penetrates complex surfaces, effectively eliminating microbes and reducing healthcare-associated infection risks.
The company has established itself as a global leader in infection prevention, with an impressive track record of protecting over 27 million patients across 30 global manufacturers and 35,000 installed units. Their cutting-edge trophon®3 device offers a streamlined, bedside-safe solution that not only ensures thorough disinfection but also provides digital traceability through cloud integration, enhancing audit readiness and workflow efficiency for healthcare professionals.
Beyond their technological innovation, Nanosonics is committed to sustainability and environmental responsibility. Their trophon® system demonstrates this commitment by converting hydrogen peroxide into eco-friendly oxygen and water, maintaining a low energy consumption of less than 2Wh per day, and ensuring that 80% of the device’s total weight is recyclable. This holistic approach positions Nanosonics as a forward-thinking company that addresses critical healthcare challenges while maintaining a strong environmental conscience.
© 2026 StockWire X Pty Ltd. All rights reserved.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.